Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 17

    1.

    Sympathetic nervous system-targeted neuropeptide Y overexpression in mice enhances neointimal formation in response to vascular injury.

    Ruohonen ST, Abe K, Kero M, Toukola L, Ruohonen S, Röyttä M, Koulu M, Pesonen U, Zukowska Z, Savontaus E.

    Peptides. 2009 Apr;30(4):715-20. Epub 2008 Dec 24.PMID: 19135490 [PubMed - indexed for MEDLINE]Related articles

    2.

    Stress-induced hypertension and increased sympathetic activity in mice overexpressing neuropeptide Y in noradrenergic neurons.

    Ruohonen ST, Savontaus E, Rinne P, Rosmaninho-Salgado J, Cavadas C, Ruskoaho H, Koulu M, Pesonen U.

    Neuroendocrinology. 2009;89(3):351-60. Epub 2008 Dec 20.PMID: 19122447 [PubMed - indexed for MEDLINE]Related articles

    3.

    Blood pressure regulation and cardiac autonomic control in mice overexpressing alpha- and gamma-melanocyte stimulating hormone.

    Rinne P, Harjunpää J, Scheinin M, Savontaus E.

    Peptides. 2008 Nov;29(11):1943-52. Epub 2008 Jun 28.PMID: 18638516 [PubMed - indexed for MEDLINE]Related articles

    4.

    Transgenic mice overexpressing neuropeptide Y in noradrenergic neurons: a novel model of increased adiposity and impaired glucose tolerance.

    Ruohonen ST, Pesonen U, Moritz N, Kaipio K, Röyttä M, Koulu M, Savontaus E.

    Diabetes. 2008 Jun;57(6):1517-25. Epub 2008 Feb 14.PMID: 18276767 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in alpha2A-adrenoceptor knockout mice.

    Savontaus E, Fagerholm V, Rahkonen O, Scheinin M.

    Eur J Pharmacol. 2008 Jan 14;578(2-3):359-64. Epub 2007 Oct 2.PMID: 17964569 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of intravenous glucose on dopaminergic function in the human brain in vivo.

    Haltia LT, Rinne JO, Merisaari H, Maguire RP, Savontaus E, Helin S, Någren K, Kaasinen V.

    Synapse. 2007 Sep;61(9):748-56.PMID: 17568412 [PubMed - indexed for MEDLINE]Related articles

    7.

    Metabolic effects of transgenic melanocyte-stimulating hormone overexpression in lean and obese mice.

    Savontaus E, Breen TL, Kim A, Yang LM, Chua SC Jr, Wardlaw SL.

    Endocrinology. 2004 Aug;145(8):3881-91. Epub 2004 Apr 29.PMID: 15117873 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion.

    Kero JT, Savontaus E, Mikola M, Pesonen U, Koulu M, Keri RA, Nilson JH, Poutanen M, Huhtaniemi IT.

    Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E812-8. Epub 2003 May 28.PMID: 12773309 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of adrenalectomy on AGRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats.

    Savontaus E, Conwell IM, Wardlaw SL.

    Brain Res. 2002 Dec 20;958(1):130-8.PMID: 12468037 [PubMed - indexed for MEDLINE]Related articles

    10.

    Leptin regulation of Agrp and Npy mRNA in the rat hypothalamus.

    Korner J, Savontaus E, Chua SC Jr, Leibel RL, Wardlaw SL.

    J Neuroendocrinol. 2001 Nov;13(11):959-66.PMID: 11737554 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of estrous cycle and steroid replacement on the expression of leptin and uncoupling proteins in adipose tissue in the rat.

    Luukkaa V, Savontaus E, Rouru J, Virtanen KA, Boss O, Huhtaniemi I, Koulu M, Pesonen U, Huupponen R.

    Gynecol Endocrinol. 2001 Apr;15(2):103-12.PMID: 11379006 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of chronic celiprolol treatment on brown fat, feeding, and drinking in fa/fa Zucker rats.

    Savontaus E, Rouru J, Malminiemi K, Luukkaa V, Pesonen U, Koulu M, Huupponen R.

    Pharmacol Biochem Behav. 2000 Apr;65(4):719-24.PMID: 10764928 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pharmacokinetics of oral entacapone after frequent multiple dosing and effects on levodopa disposition.

    Rouru J, Gordin A, Huupponen R, Huhtala S, Savontaus E, Korpela K, Reinikainen K, Scheinin M.

    Eur J Clin Pharmacol. 1999 Aug;55(6):461-7.PMID: 10492060 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of ZD7114, a selective beta3-adrenoceptor agonist, on neuroendocrine mechanisms controlling energy balance.

    Savontaus E, Pesonen U, Rouru J, Huupponen R, Koulu M.

    Eur J Pharmacol. 1998 Apr 24;347(2-3):265-74.PMID: 9653893 [PubMed - indexed for MEDLINE]Related articles

    15.

    Differential regulation of uncoupling proteins by chronic treatments with beta 3-adrenergic agonist BRL 35135 and metformin in obese fa/fa Zucker rats.

    Savontaus E, Rouru J, Boss O, Huupponen R, Koulu M.

    Biochem Biophys Res Commun. 1998 May 29;246(3):899-904.PMID: 9618309 [PubMed - indexed for MEDLINE]Related articles

    16.

    Chronic treatment with BRL 35135 potentiates the action of insulin on lipid metabolism.

    Virtanen KA, Rouru J, Hänninen V, Savontaus E, Rouvari T, Teirmaa T, Koulu M, Huupponen R.

    Eur J Pharmacol. 1997 Aug 6;332(2):215-8.PMID: 9286624 [PubMed - indexed for MEDLINE]Related articles

    17.

    Anti-obesity effect of MPV-1743 A III, a novel imidazoline derivative, in genetic obesity.

    Savontaus E, Raasmaja A, Rouru J, Koulu M, Pesonen U, Virtanen R, Savola JM, Huupponen R.

    Eur J Pharmacol. 1997 Jun 11;328(2-3):207-15.PMID: 9218703 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...